Total Payments
$7,250
2024 Payments
$1,482
Companies
42
Transactions
335
Medicare Patients
9,973
Medicare Billing
$1.0M
Payment Breakdown by Category
Food & Beverage$6,914 (95.4%)
Education$186.39 (2.6%)
Consulting$100.00 (1.4%)
Gifts$49.95 (0.7%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,914 | 330 | 95.4% |
| Education | $186.39 | 3 | 2.6% |
| Consulting Fee | $100.00 | 1 | 1.4% |
| Gift | $49.95 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,300 | 77 | $0 (2024) |
| PFIZER INC. | $612.27 | 39 | $0 (2024) |
| ACCORD HEALTHCARE, INC. | $461.44 | 11 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $440.75 | 9 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $382.43 | 26 | $0 (2024) |
| ABBVIE INC. | $378.63 | 17 | $0 (2024) |
| Boston Scientific Corporation | $364.33 | 12 | $0 (2022) |
| Janssen Biotech, Inc. | $312.70 | 14 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $306.27 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $266.66 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,482 | 65 | Sumitomo Pharma America, Inc. ($202.51) |
| 2023 | $1,780 | 72 | Myriad Genetic Laboratories, Inc. ($440.75) |
| 2022 | $1,019 | 62 | Astellas Pharma US Inc ($167.91) |
| 2021 | $1,038 | 53 | AstraZeneca Pharmaceuticals LP ($169.79) |
| 2020 | $212.97 | 12 | Astellas Pharma US Inc ($92.95) |
| 2019 | $694.36 | 24 | Astellas Pharma US Inc ($236.90) |
| 2018 | $642.99 | 27 | Astellas Pharma US Inc ($200.16) |
| 2017 | $380.63 | 20 | Astellas Pharma US Inc ($153.41) |
All Payment Transactions
335 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $30.49 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/06/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: Oncology | ||||||
| 11/26/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: HORMONE THERAPY | ||||||
| 11/19/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $25.30 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $11.56 | General |
| Category: Oncology | ||||||
| 11/05/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Oncology | ||||||
| 10/29/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: UROLOGY | ||||||
| 10/24/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $133.32 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/22/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: ONCOLOGY | ||||||
| 10/18/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: HORMONE THERAPY | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Oncology | ||||||
| 10/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Oncology | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Oncology | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: UROLOGY | ||||||
| 10/01/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/27/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/25/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $25.22 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/24/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: UROLOGY | ||||||
| 08/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 2,581 | 9,665 | $1.1M | $291,161 |
| 2022 | 31 | 2,368 | 9,394 | $701,793 | $214,132 |
| 2021 | 35 | 2,469 | 11,301 | $916,455 | $281,032 |
| 2020 | 27 | 2,555 | 8,203 | $802,532 | $225,839 |
Total Patients
9,973
Total Services
38,563
Medicare Billing
$1.0M
Procedure Codes
131
All Medicare Procedures & Services
131 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 561 | 824 | $269,820 | $68,961 | 25.6% |
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 18 | 1,008 | $187,488 | $66,667 | 35.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 172 | 579 | $73,533 | $27,761 | 37.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 25 | 192 | $134,400 | $26,333 | 19.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 71 | 87 | $62,879 | $15,321 | 24.4% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 26 | 27 | $44,600 | $11,722 | 26.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 79 | 79 | $32,783 | $8,738 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 57 | 68 | $24,755 | $8,592 | 34.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 114 | 229 | $21,984 | $8,368 | 38.1% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 29 | 29 | $23,820 | $7,893 | 33.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 53 | 68 | $17,798 | $5,211 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 66 | $17,019 | $4,219 | 24.8% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 21 | 21 | $13,696 | $3,659 | 26.7% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 29 | 34 | $12,160 | $3,507 | 28.8% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 16 | 1,250 | $6,125 | $2,820 | 46.0% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 74 | 113 | $8,029 | $2,396 | 29.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 658 | 1,015 | $10,150 | $2,215 | 21.8% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 15 | 19 | $30,277 | $2,212 | 7.3% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 225 | 282 | $10,757 | $2,075 | 19.3% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 16 | 16 | $6,952 | $2,022 | 29.1% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 17 | 26 | $6,636 | $1,666 | 25.1% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 42 | 66 | $6,773 | $1,610 | 23.8% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 16 | 16 | $10,781 | $1,596 | 14.8% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 13 | 33 | $5,870 | $1,380 | 23.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,702 | $1,230 | 33.2% |
About Dr. Christopher Vulin, MD
Dr. Christopher Vulin, MD is a Urology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1801870126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Vulin, MD has received a total of $7,250 in payments from pharmaceutical and medical device companies, with $1,482 received in 2024. These payments were reported across 335 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($6,914).
As a Medicare-enrolled provider, Vulin has provided services to 9,973 Medicare beneficiaries, totaling 38,563 services with total Medicare billing of $1.0M. Data is available for 4 years (2020–2023), covering 131 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Saint Louis, MO
- Active Since 11/30/2005
- Last Updated 12/01/2021
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1801870126
Products in Payments
- XTANDI (Drug) $1,005
- PROLARIS (Device) $440.75
- Xtandi (Drug) $432.02
- CAMCEVI (Drug) $411.49
- KEYTRUDA (Biological) $366.66
- GEMTESA (Drug) $346.39
- PROVENGE (Drug) $306.27
- ERLEADA (Drug) $293.36
- LYNPARZA (Drug) $250.57
- TRADE PROMO: SPIES FLEXC, US DEFL (Device) $199.85
- Nubeqa (Drug) $182.41
- ORGOVYX (Drug) $175.36
- JELMYTO (Drug) $172.72
- LUPRON DEPOT (Drug) $137.07
- BOTOX (Biological) $129.92
- iTIND System (Device) $129.39
- Lupron (Drug) $124.73
- Trelstar (Drug) $112.42
- MYRBETRIQ (Drug) $104.48
- PLUVICTO (Drug) $101.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Saint Louis
Dr. Gerald Andriole, Md, MD
Urology — Payments: $311,961
Urology $311,961
Mr. Travis Bullock, Md, MD
Urology — Payments: $216,655
Urology $216,655
Dr. Gurdarshan Sandhu, Md, MD
Urology — Payments: $205,354
Urology $205,354
Dr. Michael Johnson, Md, MD
Urology — Payments: $152,027
Urology $152,027
Dr. Charles Jones, Md, MD
Urology — Payments: $53,741
Urology $53,741
Gregory Mclennan, Md, MD
Urology — Payments: $35,552
Urology $35,552